Evolut PRO TAVR for Severe Aortic Stenosis with Severe LVOT Calcium
Miscellaneous StructuralCase and Plan:
69-year-old female presents with worsening NYHA Class III symptoms of heart failure for the last 3 months. Past medical history is significant for CAD, Prior PCI, HTN, HLP, DM, gastric bypass with hx for recurrent GIB due to small AVMs and osteoarthritis. Recent transthoracic echocardiogram revealed LVEF of 68%, severe valvular aortic stenosis (PG/MG/AVA/PV: 55/37/0.9/3.8), mild AR and mild MR with calcified mitral valve apparatus. CTA showed severe LVOT calcium. Her STS PROM risk for AVR was calculated at 2.4%. Heart Team evaluation found her to be at high risk for SAVR due to multiple comorbid conditions and recommended TAVR. Now planned for trans-femoral TAVR via right percutaneous femoral arterial access using a 26mm Evolut PRO+ valve with Sentinel cerebral embolic protection device.
Case Presentation
20:26
CoreValve Evolut-R TAVR (29mm) via Percutaneous Femoral Access
Week of June 14th 2016
20:02
TMVR with 29mm Sapien-3 Valve
Week of January 9th 2018
20:02
TAVR with 23mm Sapien-3
Week of November 14th 2017
20:02
Complex PCI in the setting of Severe AS
Week of April 17th 2018
20:02
Recanalization of prox RCA CTO In-stent Restenosis
Week of June 19th 2018